Ghana Health Service and International Sickle Cell Centre Launch Five-Year Partnership to Combat Sickle Cell Disease

The Ghana Health Service (GHS) has entered into a strategic five-year partnership with the International Sickle Cell Centre (ISCC) to significantly overhaul the nation’s response to sickle cell disease (SCD). Formalized through a Memorandum of Understanding (MoU), this collaboration aims to address the significant public health burden of SCD in Ghana, where approximately 18,000 infants are born with the condition every year. By focusing on a multi-pronged approach that includes early screening and comprehensive care, the initiative seeks to improve survival rates and the quality of life for thousands of affected families across the country.

The agreement is structured around five strategic priority areas: education, screening, comprehensive care, research, and health systems strengthening. A primary objective is to implement national policies more effectively, ensuring that prevention strategies and long-term management protocols reach those who need them most. Stakeholders from both the GHS and ISCC emphasized that the partnership will prioritize underserved communities, where access to specialized hematological care is often limited. By integrating SCD management into broader public health initiatives, the GHS intends to create a more resilient framework for chronic disease management.

Beyond clinical care, the partnership places a heavy emphasis on public education and awareness to destigmatize the condition and encourage genetic counseling. A national education program is currently being planned to inform the public about the importance of knowing one’s sickle cell status and the available treatment options. To ensure the initiative remains on track and achieves its long-term goals, a Joint Steering Committee has been established. This body will be responsible for coordinating efforts between the two organizations, monitoring progress, and ensuring that the implementation of the MoU remains sustainable over its five-year duration.

The signing of this MoU represents a critical step forward in Ghana’s commitment to specialized healthcare delivery. As the country continues to refine its national health strategies, the collaboration between the state health provider and a specialized international entity like the ISCC serves as a model for effective healthcare partnerships. By fostering a data-driven approach through research and health system enhancement, the GHS and ISCC aim to provide a more hopeful future for the thousands of children born with sickle cell disease in Ghana, ultimately reducing the mortality and morbidity associated with the condition.